Home > PJ (current issue) > Meetings

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7322 p616
23 October 2004

This article
Reprint   Photocopy

PDF 250K, Acrobat Reader

British Pharmaceutical Conference 2004

Positive Scottish practice

The 2004 British Pharmaceutical Conference and Exhibition “Medicines: from cell to society” took place at Manchester International Convention Centre from 27–29 September

BPC 2004 summary


Allan Thomas

Allan Thomas: service works well

One part of the new core pharmacy contract in Scotland, the minor ailments service, will be based on the direct supply of medicines project. It has already been rolled out across Ayrshire and Arran, and Tayside. Allan Thomas, community pharmacy adviser at NHS Ayrshire & Arran, explained that the objectives for the service were improving patients’ access to an appropriate health care professional, making more efficient use of the skills of GPs and community pharmacists, and encouraging joint working between GPs and pharmacists.

The scheme is open to patients exempt from prescription charges who are registered with a GP in the trust area. To use the scheme, patients must register with one pharmacy. Registration forms are then sent to the Community Health Division to be added to a database. “Patients are either given advice, medicine or referred to the GP,” said Mr Thomas. “Advice and referral are recorded on the CP1 pharmacist prescription form. This has provided an opportunity to put a number on referrals and advice given.”

Pharmacists can prescribe any pharmacy-medicine or general sale list medicine that is not blacklisted. “We ask pharmacists to prescribe from the Ayrshire & Arran joint formulary,” said Mr Thomas.

In April, 41,095 patients were registered and 3,663 CP1 forms written at a cost (for the medicines) of £7,280. The figures for May were 43,960 patients, 4,160 prescriptions and £7,960 and for June, 45,198 patients, 4,988 CP1 forms and £10,215. So roughly 10 per cent of registered patients use the service each month at a cost of about £2 per medicine prescribed.

In September, a total of 51,179 patients in Ayrshire & Arran had registered; about 20 to 25 per cent of the eligible population. “The problem with the current database is that it is paper-based. With more than 50,000 people, there is a problem with duplication so in the future centralised patient registration will be based on patients’ CHI numbers,” said Mr Thomas. “The e-pharmacy programme will allow the centralisation of the database.”

Asked about workload implications, Mr Thomas said: “On average, pharmacists are seeing five to 10 patients a day.” He added: “The service works well. One year down the line, no pharmacist has wanted to pull out.” Anecdotally, GPs have reported that since the scheme was introduced it has become easier to reach their 48-hour access targets.

Back to Top


©The Pharmaceutical Journal